RecallDepth
Class II Terminated

Rifampin Capsules USP, 300 mg, 30-count bottle; Rx Only, Manufactured for: Lupin Pharmaceuticals Baltimore, Maryland 21202, Manufactured by: Lupin Limited Aurangabad 431 210 India. NDC 68180-659-06

Company
Lupin Pharmaceuticals Inc.
Recall Initiated
December 12, 2022
Posted
January 18, 2023
Recall Number
D-0100-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
16,056 30 count bottles
Firm Location
Baltimore, MD, United States

Reason for Recall

Failed Impurities/Degradation Specifications: Failure observed in related substance testing during long term stability study.

Distribution

Distributed Nationwide in the USA

Lot / Code Info

Lot # A200171, Exp 12/2023

More recalls by Lupin Pharmaceuticals Inc.

View all recalls by this company →

Other recent Class II Drug recalls